Spironolactone not reduce primary outcome, did reduce hospitalizations for heart failure
Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not ...
Apr 9, 2014
0
0